Procter & Gamble Hygiene and Health Care shares dropped 1.1% to trade at ₹7,124 on Thursday, November 12, after the consumer goods major posted an all-around retreat across revenue, operating profit, and bottom-line earnings for the September quarter.
Sellers took control early. The company's net profit slipped 6.7% to ₹195.8 crore for the second quarter, down from ₹209.9 crore recorded in the corresponding period last fiscal year. Topline growth stalled entirely under lingering demand pressure. Revenue from operations ticked down 0.4% to ₹1,145.1 crore, compared with ₹1,150 crore in the year-ago period.
The compression was sharpest at the operating level. Earnings before interest, taxes, depreciation, and amortization (EBITDA) tumbled 8.8% to ₹260 crore, down from ₹285 crore in the prior fiscal period.
Cost burdens took an immediate bite out of profitability. Operating margin contracted 210 basis points to 22.7% from 24.8% a year earlier. Consumption volumes across core categories struggled to offset overheads, leaving little cushion on the operational front.
| Financial Metric | Q2 Current Fiscal | Q2 Previous Fiscal | YoY Change (%) |
|---|---|---|---|
| Revenue | ₹1,145.1 crore | ₹1,150.0 crore | -0.4% |
| EBITDA | ₹260.0 crore | ₹285.0 crore | -8.8% |
| EBITDA Margin | 22.7% | 24.8% | -210 bps |
| Net Profit | ₹195.8 crore | ₹209.9 crore | -6.7% |
Market Context: The earnings drop signals persistent volume friction in fast-moving consumer personal health portfolios, where pricing power faces friction against cautious urban and rural retail spending.
Management opted against pulling back on operational spending. The enterprise continued pouring cash into brand building, product upgrades, and market penetration during the quarter despite tight macro conditions, according to Managing Director Kumar Venkatasubramanian.
We continue to believe that our strategic priorities, combined with the strength of our brands and organizational capabilities, position us well to leverage future growth opportunities and create sustainable long-term value for our stakeholders," Venkatasubramanian said.
Yet reviving volume will require flawless execution. Venkatasubramanian affirmed confidence in the company's integrated growth framework, anchoring capital behind daily-use categories where functional performance dictates brand loyalty. The blueprint prioritizes product superiority, manufacturing productivity, constructive disruption, and an agile operating structure to rebuild earnings momentum as trade conditions evolve.